EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis
17 déc. 2024 05h00 HE
|
EsoCap AG
Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharmacology & TherapeuticsESO-101 leverages EsoCap’s unique drug delivery technology to...
Bioresorbable Polymers Market Report 2024, by Type (PLA, PGA, PLGA, PCL), Application (Orthopedic Devices, Drug Delivery) and Region - Global Forecast to 2029
10 déc. 2024 13h07 HE
|
Research and Markets
Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-Co-Glycolic Acid (PLGA), Polycaprolactone) PCL),...
Subcutaneous Drug Delivery Devices (Prefilled Syringes, Pen Injectors) Market Trends Analysis Report, 2025-2030 - Increasing Focus on Self-administration and Prevention of Dosing Errors Bolster Growth
19 nov. 2024 11h40 HE
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Prefilled Syringes, Pen Injectors), Distribution Channel...
Liquid Filled Capsule Market Research 2024-2034, Competitive Analysis of Lonza, Aenova, ACG, Fuji Capsule, CapsCanada, Sunil Healthcare, Ascendia, Curtis Health, Soft Gel Technologies, LiquidCapsule
18 nov. 2024 08h47 HE
|
Research and Markets
Dublin, Nov. 18, 2024 (GLOBE NEWSWIRE) -- The "Liquid Filled Capsule Market - A Global and Regional Analysis: Focus on Product, Therapeutic Application, End User, and Country - Analysis and...
Vect-Horus renforce son conseil d’administration avec la nomination de Jean-Christophe Dantonel
14 nov. 2024 03h00 HE
|
Vect-Horus
COMMUNIQUÉ DE PRESSE Professionnel expérimenté dans le secteur de la santé et scientifique accompli Jean-Christophe Dantonel apporte à...
Vect-Horus Strengthens Board of Directors with Appointment of Jean-Christophe Dantonel as New Member
14 nov. 2024 03h00 HE
|
Vect-Horus
PRESS RELEASE Accomplished research scientist and business professional Brings important skills for both clinical and business...
Non-Drug Eluting Device Market Analysis Report 2024: Global Size, Trends, Opportunities and Forecasts 2020-2030
31 oct. 2024 11h10 HE
|
Research and Markets
Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Non-Drug Eluting Device Market: Market Size, Trends, Opportunities and Forecast by Application, Material Type, End-User, Region, By Country: 2020-2030"...
Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (ONLINE EVENT: May 19-20, 2025/ON-DEMAND))
18 sept. 2024 11h18 HE
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training...
Biora Therapeutics Achieves ISO 13485 Certification
09 sept. 2024 08h00 HE
|
Biora Therapeutics, Inc.
ISO certification underscores the company’s commitment to quality and excellence
Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (LIVE EVENT: January 21-22, 2025 AND ON-DEMAND)
06 sept. 2024 06h51 HE
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training...